UnitedHealth Group Reaffirms Long-Term Earnings Growth Target of 13% to 16%
UnitedHealth Group (UNH) is demonstrating signs of a successful turnaround following a period of rising medical costs and operational challenges. In the third quarter of 2026, the company reported revenue of $112.7 billion and adjusted earnings of $4.69 per share, surpassing analyst expectations. Operating earnings saw a significant year-over-year increase, rising to $6.6 billion from $4.3 billion. Driven by its Optum division, which integrates healthcare delivery, pharmacy services, and data analytics, the company has raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share. Management reiterated a long-term annual earnings growth target of 13% to 16%, viewing the lower end of this range as a realistic baseline for 2027. The expansion of AI-driven tools within Optum Insight is also expected to enhance operational efficiency and drive future growth.